DEPRESSION DIAGNOSIS AND TREATMENT IN PARKINSON DISEASE

帕金森病的抑郁症诊断和治疗

• 批准号: 6993568
• 负责人: DANIEL WEINTRAUB
• 金额: $ 17.97万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-12-01 至 2008-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6993568
• 关键词: Parkinson' s disease; antidepressants; clinical research; comorbidity; depression; diagnosis design /evaluation; human subject; longitudinal human study; mental disorder chemotherapy; mental disorder diagnosis; pathologic process; patient oriented research; psychopathology

DESCRIPTION (provided by candidate): This grant application on behalf of Daniel Weintraub, MD, Assistant Professor of Psychiatry at the University of Pennsylvania, is for the Mentored Patient-Oriented Research Career Development Award,(K23). The focus of this award is to enable Dr. Weintraub (PI) to acquire the academic and research expertise to achieve his career goal of becoming an independent researcher in the assessment and treatment of the psychiatric complications of Parkinson's disease (PD), an area in which there is an urgent need for clinical research due to a lack of consensus over phenomenology and the lack of empirical evidence to support current treatment practice. The research plan for this award will in part involve conducting a depression screening and assessment process in two PD specialty care settings in order to determine demographic, psychiatric, neurologic, and cognitive correlates of depression and to propose modified criteria for affective disorders in PD. In conjunction with this, the PI will conduct an open-label antidepressant study using escitalopram to determine response rates under treatment as a function of different diagnostic criteria and to identify moderators of response under treatment. The impact of antidepressant treatment on comorbid psychiatric and cognitive symptoms, motor symptoms, quality of life, and caregiver burden will also be probed. Identification of modifiers of treatment response will help inform future studies and clinical decision-making. The career development plan will revolve around the acquisition of skills related to Dr. Weintraub becoming a research geriatric- and neuro-psychiatrist with expertise in Parkinson's disease and proficient in conducting intervention research in this area. The specific skill areas to be developed during the course of the proposed award relate to: (1) intervention research and biostatistics; (2) clinical neuroscience; and (3) the neurology of Parkinson's disease (PD). Methods of career development include: (1) the proposed research study; (2) the mentorship of Drs. Ira Katz and Matthew Stern; (3) consultation with experts in assessment and treatment of geriatric depression and neuropsychiatric disease; (4) formal coursework in clinical trials research, biostatistics, clinical neuroscience, and neurology; (5) training in the assessment and treatment of Parkinson's disease (6) attendance at scientific meetings; and (7) mentored data analysis and manuscript preparation.

描述（由候选人提供）：本资助申请代表丹尼尔温特劳布，医学博士，精神病学助理教授在宾夕法尼亚大学，是辅导病人为导向的研究职业发展奖，（K23）。该奖项的重点是使Weintraub博士（PI）获得学术和研究专业知识，以实现他的职业目标，成为评估和治疗帕金森病（PD）精神并发症的独立研究人员，由于缺乏对现象学的共识和缺乏支持当前治疗的经验证据，该领域迫切需要临床研究实践 该奖项的研究计划将部分涉及在两个PD专科护理环境中进行抑郁症筛查和评估过程，以确定抑郁症的人口统计学，精神病学，神经学和认知相关性，并提出PD情感障碍的修改标准。与此同时，PI将使用艾司西酞普兰进行一项开放标签抗抑郁药研究，以确定治疗下的应答率作为不同诊断标准的函数，并确定治疗下应答的调节剂。抗抑郁治疗对共病精神和认知症状、运动症状、生活质量和照顾者负担的影响也将被探讨。识别治疗反应的修饰符将有助于为未来的研究和临床决策提供信息。 职业发展计划将围绕与Weintraub博士相关的技能的获得，成为一名研究老年和神经精神病学家，具有帕金森病的专业知识，并精通在这一领域进行干预研究。在拟议的奖项过程中将开发的具体技能领域涉及：（1）干预研究和生物统计学;（2）临床神经科学;和（3）帕金森病（PD）的神经学。职业发展的方法包括：（1）建议的研究性学习;（2）伊拉·卡茨和马修·斯特恩博士的指导;（3）咨询老年抑郁症和神经精神疾病的评估和治疗专家;（4）临床试验研究、生物统计学、临床神经科学和神经病学的正式课程;（5）帕金森病评估和治疗方面的培训;（6）参加科学会议;以及（7）指导数据分析和手稿准备。